Renal sympathetic activation from long-term low-dose angiotensin II infusion in rabbits

Journal of Hypertension

Volumn 30, Issue 3, 2012, Pages 551-560

  Moretti, John Luis ^a   Burke, Sandra L ^a   Davern, Pamela J ^a   Evans, Roger G ^b   Lambert, Gavin W ^a   Head, Geoffrey A ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

angiotensin II hypertension; blood pressure; ganglion blockade; heart rate; rabbits; sympathetic nervous system

Indexed keywords

ANGIOTENSIN II; NORADRENALIN; PROTEIN FOS; RENIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN NERVE CELL; CONFERENCE PAPER; CONTROLLED STUDY; ELECTRODE; EXPERIMENTAL RABBIT; HEART RATE; HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOXIA; KIDNEY BLOOD FLOW; KIDNEY INNERVATION; KIDNEY VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORGANUM VASCULOSUM OF THE LAMINA TERMINALIS; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STRESS; SUPRAOPTIC NUCLEUS; SYMPATHETIC TONE; TACHYCARDIA;

EID: 84857060387     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328350133a     Document Type: Conference Paper

References (54)

1. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376:1903-1909.
2. Esler MD, Lambert EA, Schlaich M, Navar LG. The dominant contributor to systemic hypertension: chronic activation of the sympathetic nervous system vs activation of the intrarenal renin-angiotensin system. J Appl Physiol 2010; 109:1996-1998.
3. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 2004; 43:169-175. (Pubitemid 38174169)
4. Osborn JL, Plato CF, Gordin E, He XR. Long-term increases in renal sympathetic nerve activity and hypertension. Clin Exp Pharmacol Physiol 1997; 24:72-76. (Pubitemid 27101493)
5. Esler MD, Lambert GW, Ferrier C, Kaye DM, Wallin BG, Kalff V, et al. Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Clin Exp Hypertens 1995; 17:409-423.
6. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373:1275-1281.
7. Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, et al. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens 2011; 29:991-996.
8. Schlaich MP, Krum H, Sobotka PA, Esler MD. Renal denervation and hypertension. Am J Hypertens 2011; 24:635-642.
9. Schlaich MP, Krum H, Sobotka PA. Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension. Curr Hypertens Rep 2010; 12:39-46.
10. Dendorfer A, Thornagel A, Raasch W, Grisk O, Tempel K, Dominiak P. Angiotensin II induces catecholamine release by direct ganglionic excitation. Hypertension 2002; 40:348-354. (Pubitemid 35006722)
11. Davern PJ, Head GA. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension 2007; 49:1170-1177. (Pubitemid 351664323)
12. DiBona GF, Jones SY. Sodium intake influences hemodynamic and neural responses to angiotensin receptor blockade in rostral ventrolateral medulla. Hypertension 2001; 37:1114-1123. (Pubitemid 32304013)
13. Luft FC, Wilcox CS, Unger T, Kuhn R, Demmert G, Rohmeiss P, et al. Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins. Hypertension 1989; 14:396-403. (Pubitemid 19256541)
14. Petersson MJ, Rundqvist B, Johansson M, Eisenhofer G, Lambert G, Herlitz H, et al. Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens 2002; 20:1181-1187. (Pubitemid 34913638)
15. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G, et al. Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999; 99:2537-2542. (Pubitemid 29228284)
16. Brooks VL. Interaction between angiotensin II and the sympathetic nervous system in the long-term control of arterial pressure. Clin Exp Pharmacol Physiol 1997; 24:83-90. (Pubitemid 27101495)
17. Osborn JW, Jacob F, Guzman P. A neural set point for the long-term control of arterial pressure: beyond the arterial baroreceptor reflex. Am J Physiol 2005; 288:R846-R855. (Pubitemid 40404157)
18. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 2007; 9:228-235. (Pubitemid 46900043)
19. Burke SL, Evans RG, Head GA. Effects of chronic sympatho-inhibition on renal excretory function in renovascular hypertension. J Hypertens 2011; 29:945-952.
20. Burke SL, Evans RG, Head GA. Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension. Br J Pharmacol 2010; 159:438-448.
21. Burke SL, Lambert E, Head GA. New approaches to quantifying sympathetic nerve activity. Curr Hypertens Rep 2011; 13:249-257.
22. Barrett CJ, Ramchandra R, Guild SJ, Lala A, Budgett DM, Malpas SC. What sets the long-term level of renal sympathetic nerve activity: a role for angiotensin II and baroreflexes? Circ Res 2003; 92:1330-1336. (Pubitemid 36773475)
23. Head GA, Burke SL. Sympathetic responses to stress and rilmenidine in 2K1C hypertensive rabbits: evidence of enhanced nonvascular neuroeffector mechanism. Hypertension 2004; 43:636-642. (Pubitemid 38282440)
24. Bell LB. Baroreflex modulation by isoflurane anesthesia in normotensive and chronically hypertensive rabbits. Adv Pharmacol 1994; 31:389-408.
25. Head GA, Burke SL. Renal and cardiac sympathetic baroreflexes in hypertensive rabbits. Clin Exp Pharmacol Physiol 2001; 28:972-975. (Pubitemid 34053503)
26. Moretti J-L, Burke SL, Evans RG, Lambert GW, Head GA. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension. J Hypertens 2009; 27:1838-1848.
27. Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL, Montani J-P, et al. Exposure to a high fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 2010; 55:862-868.
28. Korner P. Essential hypertension and its causes: neural and non neural mechanisms. New York, New York: Oxford University Press; 2007.
29. Denton KM, Lamden M, Shweta A, Alcorn D, Anderson WP. Chronic angiotensin converting enzyme inhibition enhances renal vascular responsiveness to acetylcholine in anaesthetized rabbits. J Hypertens 2001; 19:1497-1503. (Pubitemid 32730468)
30. Oliver JR, Korner PI, Woods RL, Zhu JL. Reflex release of vasopressin and renin in haemorrhage is enhanced by autonomic blockade. Am J Physiol Heart Circ Physiol 1990; 258:H221-H228. (Pubitemid 20063132)
31. Dorward PK, Riedel W, Burke SL, Gipps J, Korner PI. The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ Res 1985; 57:618-633. (Pubitemid 16233128)
32. Burke SL, Head GA. Cardiac and renal baroreflex control during stress in conscious renovascular hypertensive rabbits: Effect of rilmenidine. J Hypertens 2009; 27:132-141.
33. Medvedev OS, Esler MD, Angus JA, Cox HS, Eisenhofer G. Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol 1990; 341:192-199. (Pubitemid 20102207)
34. Burke SL, Head GA. Method for in-vivo calibration of renal sympathetic nerve activity in rabbits. J Neurosci Meth 2003; 127:63-74. (Pubitemid 36809235)
35. Ricketts JH, Head GA. A five parameter logistic equation for investigating asymmetry of curvature in baroreflex studies. Am J Physiol Regul Integr Comp Physiol 1999; 277:R441-R454. (Pubitemid 29415114)
36. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 1994; 28:303-311. (Pubitemid 24131066)
37. Evans RG, Burke SL, Lambert GW, Head GA. Renal responses to acute reflex activation of renal sympathetic nerve activity and renal denervation in secondary hypertension. Am J Physiol Regul Integr Comp Physiol 2007; 293:R1247-R1256. (Pubitemid 47358947)
38. McKenzie JK, Ryan JW, Lee MR. Effect of laparotomy on plasma renin activity in the rabbit. Nature 1967; 215:542-543.
39. Dorward PK, Bell LB, Rudd CD. Cardiac afferents attenuate renal sympathetic baroreceptor reflexes during acute hypertension. Hypertension 1990; 16:131-139. (Pubitemid 20230836)
40. Barrett CJ, Guild SJ, Ramchandra R, Malpas SC. Baroreceptor denervation prevents sympathoinhibition during angiotensin II-induced hypertension. Hypertension 2005; 46:168-172. (Pubitemid 40946509)
41. Burke SL, Evans RG, Moretti J-L, Head GA. Levels of renal and extrarenal sympathetic drive in Ang II-induced hypertension. Hypertension 2008; 51:878-883. (Pubitemid 351654699)
42. Head GA, Minami N. Importance of cardiac but not vascular hypertrophy in the cardiac baroreflex deficit in spontaneously hypertensive and stroke prone rats. Am J Med 1992; 92:S54-S59.
43. Head GA, Minami N, Adams MA, Bobik A. Development of cardiac hypertrophy and its relation to the cardiac baroreflex deficit in hypertension. J Hypertens 1991; 9:S80-S81.
44. Minami N, Head GA. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats. J Hypertens 1993; 11:523-533. (Pubitemid 23154343)
45. Thomas CJ, Head GA, Woods RL. ANP and bradycardic reflexes in spontaneously hypertensive rats: influence of cardiac hypertrophy. Hypertension 1998; 32:548-555. (Pubitemid 28429147)
46. Wright CE, Angus JA. Enhanced total peripheral vascular responsiveness in hypertension accords with the amplifier hypothesis. J Hypertens 1999; 17:1687-1696.
47. Li YL, Xia XH, Zheng H, Gao L, Li YF, Liu D, et al. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc Res 2006; 71:129-138. (Pubitemid 43849673)
48. Phillips BG, Somers VK. Neural and humoral mechanisms mediating cardiovascular responses to obstructive sleep apnea. Resp Physiol 2000; 119:181-187. (Pubitemid 30155573)
49. Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension 2003; 42:1067-1074. (Pubitemid 37549057)
50. Ziegler MG, Milic M, Sun P. Antihypertensive therapy for patients with obstructive sleep apnea. Curr Opin Nephrol Hypertens 2011; 20:50-55.
51. da Silva AQ, Fontes MA, Kanagy NL. Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea. Brain Res 2011; 1368:231-238.
52. de Wardener HE. The hypothalamus and hypertension. Physiol Rev 2001; 81:1599-1658. (Pubitemid 32947779)
53. Stotz-Potter EH, Morin SM, DiMicco JA. Effect of microinjection of muscimol into the dorsomedial or paraventricular hypothalamic nucleus on air stress-induced neuroendocrine and cardiovascular changes in rats. Brain Res 1996; 742:219-224. (Pubitemid 27016026)
54. Badoer E. Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin Exp Pharmacol Physiol 2001; 28:95-99. (Pubitemid 32039567)